EOEvren Ozcinar

Evren Ozcinar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Evren Ozcinar has a total of 306 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparing Reintervention Factors in Acute Deep Vein Thrombosis and Post-Thrombotic Syndrome

    by Ahmet Kayan, Ali Fuat Karaçuha, Ali Batuhan Yenigün, Evren Özçınar, Çağdaş Baran, Fatma Akça, Cahit Sarıca, Mustafa Şırlak, Nur Dikmen, Ali İhSan Hasde, et al.

    Background: Acute iliofemoral deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS) are characterized by significant morbidity due to impaired venous drainage. Although technical success in endovascular interventions is increasing, the need for reintervention due to complications like stent thrombosis and restenosis remains the primary obstacle to long-term clinical success.Objective: This study aims to compare clinical characteristics and intraoperative findings requiring reintervention in acute DVT and PTS patients to optimize patient-specific follow-up and management strategies.Materials and Methods: We retrospectively evaluated 400 patients (184 Acute DVT, 216 PTS) who underwent iliofemoral venous stenting. A subgroup of 111 patients (51 Acute DVT, 60 PTS) undergoing reintervention for clinical or radiological failure was analyzed. Groups were statistically compared regarding demographics, reintervention indications, and intraoperative findings.Results: The 12-month primary patency rates were 72.5% for Acute DVT and 68.3% for PTS. Among those requiring reintervention, the PTS group had significantly higher rates of recent surgery/trauma (53.3% vs. 27.5%; p=0.010) and recurrent venous ulcers (48.3% vs. 23.5%; p=0.012). Intraoperatively, in-stent restenosis (ISR) was more frequent in the PTS group (66.7% vs. 47.1%; p=0.038). In the Acute DVT group, masked anatomical issues predominated, specifically contralateral outflow obstruction (15.7% vs. 3.3%; p=0.042) and untreated additional venous lesions (47.1% vs. 23.3%; p=0.015). Secondary patency rates remained high in both groups (90.2% and 85.1%).Conclusion: Reintervention etiologies for acute DVT and PTS differ significantly. Failure in PTS is associated with chronic ISR and ulcer recurrence, while missed anatomical lesions during the index procedure are decisive in acute DVT. Extensive anatomical mapping in acute cases and aggressive restenosis monitoring in PTS are critical for long-term success.

  • Open Access

    Mid-Term Clinical Outcomes of the Low-Profile Ankura™ Stent Graft System for Endovascular Aneurysm Repair

    by Fatma Akca Ozsar, Bekir Bogachan Akkaya, Mehmet Cahit Saricaoglu, Onur Buyukcakir, Evren Ozcinar, Hakki Zafer Iscan, Levent Yazicioglu

    Background: To evaluate the real-world safety and mid-term clinical performance of the Ankura™ AAA Stent Graft System in patients undergoing endovascular aneurysm repair (EVAR). Materials and Methods: This prospective, multicenter PMCF study analyzed 100 patients with abdominal aortic aneurysms (AAAs). Patients were monitored for a mean duration of 2.26 years. Primary endpoints included 30-day major adverse events and 24-month treatment success. Statistical evaluation of risk factors for reintervention was performed using univariate logistic regression. Results: The study cohort was predominantly male (97%), with a mean age of 72.01 years. Hypertension (90%) and smoking (89%) were the most prevalent comorbidities. Regarding the primary endpoints, the 30-day MAE rate was 2%. During the overall follow-up (mean 2.26 years), the primary patency rate was 97%, demonstrating high structural integrity and sustained patency. However, the overall freedom from reintervention rate was 74%, corresponding to a 26% reintervention requirement and a 27% incidence of endoleak. Reinterventions were almost exclusively driven by these post-procedural morphological complications; specifically, 26 of the 27 patients with endoleaks required a secondary procedure. No preoperative clinical or anatomical parameters were identified as significant independent predictors of reintervention in the univariate analysis (p > 0.05). The overall mortality rate was 12%, with 0% aneurysm-related mortality. Conclusions: Mid-term success and reintervention after EVAR with the Ankura™ system are primarily driven by postoperative morphological complications, such as endoleaks, rather than baseline patient risk profiles. These findings underscore the critical importance of rigorous, lifelong radiological surveillance regardless of preoperative anatomical challenges.


  • Kalp ve Damar Cerrahisinde Kalite Yönetimi ve Risk Kademelendirmesi

    by İsmet Onur Tanıyan, Mehmet Cahit Sarıcaoğlu, Salih Anıl Boğa, Mizgin Tapkan, Giorgi Sulukhia, Ahmet Kayan, Evren Özçınar, Ahmet Rüçhan Akar

    Bu bölüm, kalp ve damar cerrahisinde risk kademelendirme uygulamalarının tarihsel gelişimini, bilimsel temellerini, güncel modellerini ve gelecekteki yönelimlerini kapsamlı şekilde ele almaktadır. Risk kavramı, yalnızca olasılığı değil aynı zamanda sonuçların ciddiyetini ve bireye özgü değişkenleri de içeren çok boyutlu bir değerlendirme olarak tanımlanmıştır. Modern tıpta bu yaklaşım; mortalite, morbidite, yaşam kalitesi ve tekrar hastaneye yatış gibi sonlanım noktalarını kapsamaktadır.Tarihsel gelişim sürecinde Florence Nightingale, John Hunter, Ernest Codman ve Archie Cochrane gibi öncülerin çalışmaları, hasta verilerinin sistematik kaydının ve analizinin risk kademelendirme temellerini oluşturduğunu göstermektedir. Cerrahi sonuçların önceden öngörülmesi amacıyla geliştirilen ilk modeller arasında Parsonnet ve SUMMIT sistemleri yer almakta olup; günümüzde EuroSCORE II ve STS (Society of Thoracic Surgeons) gibi validasyonu yapılmış, geniş veri setlerine dayalı sistemler ön plana çıkmaktadır.EuroSCORE II modeli, özellikle Avrupa ülkelerinde kalp cerrahisi mortalite riskinin öngörülmesinde en sık kullanılan araçlardan biri olup, hastaya ve işleme özgü faktörleri dikkate alan bir lojistik regresyon sistemiyle çalışmaktadır. Türkiye özelinde geliştirilen TurcoSCORE projesi, ulusal düzeyde veri tabanlı risk tahmininin önemini vurgulamakla birlikte, sürdürülebilirliğin sağlanamaması nedeniyle sınırlı kalmıştır.Günümüzde yapay zekâ (AI) ve makine öğrenmesi (ML) tekniklerinin entegrasyonu ile daha bireyselleştirilmiş ve hassas risk tahmin sistemleri geliştirilmektedir. Özellikle radyolojik görüntüleme, biyobelirteçler ve frailty değerlendirmesi gibi çoklu veri kaynaklarının birleştirilmesi, ani kardiyak ölüm gibi yüksek riskli sonuçların daha doğru tahmin edilmesini mümkün kılmaktadır.Sonuç olarak, kalp cerrahisinde risk kademelendirme, yalnızca klinik karar desteği değil, aynı zamanda etik sorumluluk, hasta eğitimi ve sağlık sisteminde kalite yönetimi açısından da vazgeçilmez bir uygulamadır.

  • Open Access

    Kalp ve Damar Cerrahisi (Cilt 1-2)

    by Ayşen Yaprak Kapkın, Hakan Hançer, Günseli Çubukçuoğlu Deniz, Cüneyt Konuralp, Serpil Nalbant, Mehmet Çakıcı, Deniz Süha Küçükaksu, Tümer Ulus, Onur Benli, Hafize Yalınız, et al.

  • Open Access

    Early outcomes of TEVAR: Spinal cord ischemia and reintervention rates in a single-center study

    by Mehmet Cahit Saricaoglu, Fatma Akca, Evren Ozcinar, Ali Ihsan Hasde, Salih Anil Boga, Ali Fuat Karacuha, Onur Buyukcakir, Cagdas Baran, Levent Yazicioglu, Sadik Eryilmaz

    Aim: Thoracic endovascular aortic repair (TEVAR) is currently the preferred treatment for different pathologies of the thoracic aorta because of its technical advantages over open surgery. This single-center study analyzes early outcomes of TEVAR with a special focus on spinal cord ischemia (SCI) and reintervention rates and their relationship to patient and procedural variables. Material and Methods: Data were retrospectively collected from patients who underwent TEVAR between February 2012 and August 2023. Patients were classified by pathology type: thoracic aortic aneurysms (n=97, 66.4%), type B aortic dissections (n=28,19.2%), traumatic aortic injuries (n=12, 8.2%), and other pathologies (n=9, 6.2%). Primary outcomes included SCI and reintervention rates at one year post-procedure; secondary outcomes included stroke, upper extremity ischemia, and 30-day mortality. The statistical analysis used univariate and multivariate logistic regression models as well as Kaplan-Meier survival analyses with subgroup comparisons between elective and urgent cases.Results: A total of 146 patients were analyzed; 79.45% were male with an average age of 63.23±12.50 years. Of this population, 121 patients (82.9%) had elective procedures and 25 patients (17.2%) had urgent/emergent procedures; postoperative spinal cord ischemia developed in 11 patients (7.5%). The stroke rate was 13.7% (n=20).The 30-day mortality rate was significantly higher in patients undergoing urgent TEVAR compared to those undergoing elective procedures (32.0% vs. 13.2%, p=0.02). TEVAR-related reintervention was required within a year for 38 patients (26%).There are no independent predictors for spinal cord ischemia; however, the multivariate analysis shows that early reintervention has a strong association with diabetes mellitus (OR 3.2, 95% CI 1.3–7.8, p=0.01), history of smoking (OR 2.1, 95% CI 1.0–4.4, p=0.05), and lesions in distal zones (OR 2.4, 95% CI 1.1–5.2, p=0.03). Urgent cases showed a trend toward higher reintervention rates compared to elective procedures (40.0% vs. 23.1%, p=0.08). Conclusion: This study demonstrates that the risk of reintervention is increased in cases with a history of diabetes mellitus, smoking, and aortic pathologies located in the distal thoracic zone. Urgent procedures carry higher morbidity and mortality risks but should be confirmed by larger randomized multicenter studies.

  • Predictors of Mortality Correlated with the SOFA Score in Pediatric VA-ECMO Patients

    by Nur Dikmen, Zeynep Eyıleten, Oğuzhan Durmaz, Evren Özçınar, Burcu Arıcı, Ahmet Kayan, Ali Fuat Karaçuha, Merve Havan, Fatma Akça, Tayfun Uçar, et al.

    Background: The objective of this study was to analyze mortality predictors in pediatric VA-ECMO patients, correlating these predictors with the pediatric sequential organ failure assessment score (pSOFA). Aim: To enhance prognostic accuracy and support individualized clinical decision-making by evaluating the correlations between mortality predictors and pediatric sequential organ failure assessment (pSOFA) scores in pediatric VA-ECMO patients. Methods: We conducted a retrospective analysis of 80 consecutive pediatric VA-ECMO cases treated at our center between April 2018 and October 2021. Data collection included patient demographics, clinical features, pSOFA scores, and estimated mortality risks. Survival impacts and morbidity factors were also assessed. The overall decannulation and hospital discharge rates were recorded, with a particular focus on patients with congenital cardiac diseases and those experiencing postcardiotomy low cardiac output, who showed the highest survival rates. Results: Our analysis revealed that certain variables significantly influenced survival outcomes in pediatric VA-ECMO patients. These variables included age, weight, genetic disorders, inotropic support, inhaled nitric oxide (NO) usage, hemodiafiltration, duration of hospital stay, active cardiopulmonary resuscitation during cannulation, and various biochemical markers. Notably, the mean pSOFA scores were significantly lower in survivors compared to non-survivors (9.22 ± 1.43 vs. 13.06 ± 2.69, respectively). Overall decannulation and hospital discharge rates were 60% and 48.75%, respectively, with the highest rates observed in patients with congenital cardiac diseases and postcardiotomy low cardiac output (84.6% and 76.9%, respectively). Furthermore, several mortality predictors were identified, which correlated strongly with pSOFA scores. These predictors included the need for inotropic support, elevated levels of lactate and creatinine, a low protein/albumin ratio, and a low pH prior to cannulation. These findings underscore the critical importance of assessing the severity of organ failure and the overall clinical status when determining mortality risk in pediatric VA-ECMO patients. Conclusion: This study offers valuable insights into the association between pSOFA scores and mortality predictors in pediatric ECMO cases. The significant correlation between higher pSOFA scores and increased mortality highlights the necessity for comprehensive risk assessment and vigilant monitoring of clinical status to optimize patient outcomes. Our findings support the integration of pSOFA scores into routine clinical practice for more effective prognostication and individualized patient management in pediatric VA-ECMO.

  • Open Access

    Early Outcomes of TEVAR: Spinal Cord Ischemia and Reintervention Rates in a Single-Center Study

    by Mehmet Cahit Sarıcaoğlu, Fatma Akça, Evren Özçınar, Ali İhsan Hasde, Salih Anil Boğa, Ali Fuat Karaçuha, Onur Büyükçakır, Çağdaş Baran, Levent Yazıcıoğlu, Sadik Eryilmaz

    Objective: Thoracic endovascular aortic repair (TEVAR) has become the preferred treatment for various thoracic aortic pathologies due to its technical advantages over open surgery. This single-center study aims to analyze early outcomes of TEVAR, specifically focusing on spinal cord ischemia (SCI) and reintervention rates, while examining their relationships with patient and procedural variables. Methods: Data from patients who underwent TEVAR between February 2012 and August 2023 were retrospectively collected. Patients were categorized by pathology type: thoracic aortic aneurysms (n=97, 66.4%), type B aortic dissections (n=28,19.2%), traumatic aortic injuries (n=12, 8.2%), and other pathologies (n=9, 6.2%).Primary outcomes were spinal cord ischemia and 1-year reinterventions rates. Secondary outcomes included stroke, upper extremity ischemia, and 30-day mortality. Statistical analysis included univariate and multivariate logistic regression, Kaplan-Meier survival analysis, and subgroup comparisons between elective and urgent cases. Results: In the dataset of 146 patients, 116 (79.45%) were male, with an average age of 63.23 ± 12.50. Elective procedures were performed in 121 patients (82.9%) versus 25 urgent cases (17.2%). Among the complications, postoperative stroke was observed in 20 patients (13.7%), and upper extremity ischemia, likely due to occlusion of the subclavian artery, was observed in 10 patients (6.84%). Spinal cord ischemia was observed in 11 patients (7.5%), while TEVAR-related reintervention was required in 38 patients (26%). No significant relationship was found between SCI and the variables (p-value > 0.05); however, reintervention was required in 38 patients (26.0%) and was significantly associated with diabetes mellitus (OR 3.2, 95% CI 1.3-7.8, p=0.01), smoking history (OR 2.1, 95% CI 1.0-4.4, p=0.05), and distal zone lesions (OR 2.4,95% CI 1.1-5.2, p=0.03). Overall 30-day mortality was 17.1%. Urgent cases had higher 30-day mortality (32.0% vs. 13.2%, p=0.02) and reintervention rates (40.0% vs. 23.1%, p=0.08). Conclusions: This study demonstrates that the risk of reintervention is increased in cases with a history of diabetes mellitus, smoking, and aortic pathologies located in the distal thoracic zone. Urgent procedures carry higher morbidity and mortality risks. However, the current findings need to be supported by larger randomized multicenter studies.

  • Open Access

    Comparative Outcomes of Catheter-Directed Thrombolysis and Open Surgical Revascularization in Early-Stage Acute Limb Ischemia: Real-World Evidence from a Retrospective Cohort Study

    by Mehmet Cahit Sarıcaoğlu, Salih Anil Boga, Ismet Onur Taniyan, Melisa Kandemir, Fatma Akça, Ahmet Kayan, Ebru Ozturk, Nur Dikmen, Ali Ihsan Hasde, Cagdas Baran, et al.

    Background: Acute limb ischemia (ALI) is a vascular emergency where timely revascularization is crucial for limb salvage and survival. While open surgical revascularization (OSR) has been the traditional standard, catheter-directed thrombolysis (CDT) has emerged as a minimally invasive alternative. Comparative real-world evidence in early-stage ALI (Rutherford I–IIa) remains limited. Methods: We conducted a retrospective single-center cohort study including 36 patients with ALI treated between 2019 and 2023 (OSR: n=24; CDT: n=12). Demographics, comorbidities, procedural details, and outcomes were analyzed. The primary endpoint was a composite of in-hospital mortality, primary patency, and secondary patency. Secondary endpoints included amputation, cerebrovascular events, renal function, and hospital stay. Effect sizes with 95% confidence intervals were reported alongside p-values to address type II error risk. Results: Baseline characteristics were comparable between groups. Both OSR and CDT significantly improved ankle-brachial index (0.64 ± 0.43 to 0.93 ± 0.33, p< 0.001) and postoperative arterial patency. At 12 months, primary patency was 66.7% (OSR) vs. 50.0% (CDT), and secondary patency was 79.2% vs. 75.0% (p>0.05). Major amputation (12.5% vs. 16.7%) and mortality (8.3% vs. 16.7%) rates did not differ significantly. Hospital stay was longer after OSR (7.29 ± 4.58 vs. 6.08 ± 8.75 days, p=0.038). Fibrinogen levels decreased significantly during CDT, but no major bleeding events occurred. Conclusion: Both OSR and CDT provide effective revascularization in early ALI, with comparable limb salvage and survival outcomes. CDT offers a minimally invasive alternative with acceptable safety when accompanied by careful monitoring, whereas OSR remains a reliable option with immediate reperfusion. Larger multicenter studies are needed to refine patient selection and optimize treatment algorithms.

  • Open Access

    Total Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results

    by Evren Ozcinar, Fatma Akca, Mehmet Cahit Saricaoglu, Ali Ihsan Hasde, Nur Dikmen, Onur Buyukcakir, Aysegul Guven, Oguzhan Durmaz, Salih Anil Boga, Ali Fuat Karacuha, et al.

    Background: Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair (TEVAR) to include arch lesions. In situ needle fenestration (ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and Methods: A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024. The median age of the patients was 51,33 years (±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 min (range: 126–302). Two patients experienced a minor hematoma at the access site. Mortality was observed in one patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia. No procedure-related endoleak was observed during the intervention; however, eight patients required reintervention in the descending aorta. Conclusions: ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.


  • Open Access

    Total Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results

    by Evren Ozcinar, Fatma Akça, Mehmet Cahit Saricaoglu, Ali Ihsan Hasde, Nur Dikmen, Onur Buyukcakir, Aysegul Güven, Oğuzhan Durmaz, Salih Anıl Boğa, Ali Fuat Karacuha, et al.

    Background:Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair(TEVAR) to include arch lesions.In situ needle fenestration(ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and methods:A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024.The median age of the patients was 51,33 years(±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 minutes (range: 126–302).Two patient experienced a minor hematoma at the access site. Mortality was observed in 1 patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia.No procedure-related endoleak was observed during the intervention; however, 8 patients required reintervention in the descending aorta. Conclusion:ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.